Polymyositis - adult
St. Luke's Hospital
Main Number: 314-434-1500 Emergency Dept: 314-205-6990 Patient Billing: 888-924-9200
Find a Physician Payment Options Locations & Directions
Follow us on: facebook twitter Mobile Email Page Email Page Print Page Print Page Increase Font Size Decrease Font Size Font Size
America's 50 Best Hospitals
Meet the Doctor
Spirit of Women
Community Health Needs Assessment
Home > Health Information

Senior's Center

Polymyositis - adult

Definition

Polymyositis is a relatively uncommon inflammatory disease that leads to muscle weakness, swelling (inflammation), tenderness, and damage. It is part of a larger group of diseases called myositis.

Causes

Polymyositis is a skeletal muscle disease that is also known as idiopathic inflammatory myopathy. The cause is unknown. An autoimmune reaction or infection of the skeletal muscle may cause the disease.

Polymyositis can affect people at any age, but it most commonly occurs between ages 50 and 70, or in children ages 5 to 15. It affects women twice as often as men. It is more common in African Americans than Caucasians. Overall, about 1 in 100,000 people are diagnosed with some form of inflammatory myopathy each year.

Other types of inflammatory muscle diseases exist, including inclusion body myositis.

Symptoms

Polymyositis is a systemic disease, which means it affects the whole body. Symptoms include:

  • Difficulty swallowing
  • Muscle pain
  • Muscle weakness in the proximal muscles (shoulders, hips, etc.) that makes it difficult to raise the arms over the head, get up from a sitting position, or climb stairs
  • Problems with the voice (caused by weak throat muscles)
  • Shortness of breath

Patients may also have:

  • Fatigue
  • Fever
  • Joint pain
  • Loss of appetite
  • Morning stiffness
  • Weight loss

A similar condition called dermatomyositis causes a reddish-purple or red rash on the face or body.

Exams and Tests

Muscle weakness and tenderness can be signs of polymyositis. A rash is a sign of a similar condition, dermatomyositis.

Tests may include:

  • Autoimmune antibodies and inflammation tests
  • CPK
  • Electromyography
  • MRI of affected muscles
  • Muscle biopsy
  • Myoglobin in the urine
  • Serum aldolase

Patients with this condition must be carefully monitored for cancer.

Treatment

The main treatment is with corticosteroid medications. When muscle strength improves, usually in 4 to 6 weeks, the medication is slowly tapered off. Maintenance therapy with prednisone may be continued indefinitely. In people who fail to respond to corticosteroids, medications to suppress the immune system, such as methotrexate and azathioprine, may be used.

Intravenous gamma globulin has been tried, with mixed results. It is too soon to know what role biologic drugs may play in treating this condition.

If the condition is associated with a tumor, it may improve if the tumor is removed.

Outlook (Prognosis)

Response to treatment varies, and it depends on whether there are complications. The 5-year mortality can be as high as 20%.

Many patients, especially children, go into remission (a period when no symptoms are present) and recover. For most other people, immunosuppressant drugs can control the disease.

In adults, death may result from:

  • Malnutrition
  • Pneumonia
  • Respiratory failure
  • Severe, long-term muscle weakness

The major causes of death are cancer (malignancy) and lung disease.

Possible Complications

  • Calcium deposits in the affected muscles, especially in children with the disease
  • Cancer
  • Heart disease, lung disease, or abdominal complications

When to Contact a Medical Professional

Call your health care provider if you have symptoms of this disorder. Seek emergency treatment if you have shortness of breath and difficulty swallowing.

References

Harris ED, Budd RC, Genovese MC, Firestein GS, Sargent JS, Sledge CB. Kelley's Textbook of Rheumatology. 7th ed. St. Louis, Mo: WB Saunders; 2005:1312-1316.

Goldman L, Ausiello D. Goldman: Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders; 2007.



Review Date: 2/7/2011
Reviewed By: Michael E. Makover, MD, professor attending in Rheumatology at the New York University Medical Center, New York, NY. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com


Back  |  Top
About Us
Contact Us
History
Mission
Locations & Directions
Quality Reports
Annual Reports
Honors & Awards
Community Health Needs
Assessment

Newsroom
Services
Brain & Spine
Cancer
Heart
Maternity
Orthopedics
Pulmonary
Sleep Medicine
Urgent Care
Women's Services
All Services
Patients & Visitors
Locations & Directions
Find a Physician
Tour St. Luke's
Patient & Visitor Information
Contact Us
Payment Options
Financial Assistance
Send a Card
Mammogram Appointments
Health Tools
My Personal Health
mystlukes
Spirit of Women
Health Information & Tools
Clinical Trials
Health Risk Assessments
Employer Programs -
Passport to Wellness

Classes & Events
Classes & Events
Spirit of Women
Donate & Volunteer
Giving Opportunities
Volunteer
Physicians & Employees
For Physicians
Remote Access
Medical Residency Information
Pharmacy Residency Information
Physician CPOE Training
Careers
Careers
St. Luke's Hospital - 232 South Woods Mill Road - Chesterfield, MO 63017 Main Number: 314-434-1500 Emergency Dept: 314-205-6990 Patient Billing: 888-924-9200
Copyright © St. Luke's Hospital Website Terms and Conditions  |  Privacy Policy  |  Patient Notice of Privacy Policies PDF Sitemap St. Luke's Mobile